The Opposing Roles of PIK3R1/p85α and PIK3R2/p85β in Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The phosphoinositide 3-kinase (PI3K)/phosphatase and tensin homolog (PTEN) pathway is frequently dysregulated in various cancers.
• PIK3CA and PTEN are among the most commonly mutated genes in cancer, second only to TP53.
• PIK3R1 is the primary regulatory isoform of PI3K, while PIK3R2, an often overlooked isoform, shows increased expression in cancer.

Purpose of the Study:

• To review the contrasting functions of PIK3R1 and PIK3R2 in cancer development and progression.
• To elucidate the regulatory mechanisms governing PIK3R2 expression.
• To discuss novel therapeutic strategies targeting PIK3R2 in oncogenesis.

Main Methods:

• Literature review of existing research on PI3K/PTEN pathway in cancer.
• Analysis of The Cancer Genome Atlas (TCGA) data for PIK3R2 expression patterns.
• Synthesis of information on oncogenic and tumor-suppressive roles of PI3K isoforms.

Main Results:

• PIK3R1 acts as a tumor suppressor, whereas PIK3R2 functions as an oncogene.
• Increased PIK3R2 expression is a common finding in cancer, suggesting its oncogenic potential.
• Understanding PIK3R2 regulation is key to developing targeted cancer therapies.

Conclusions:

• PIK3R1 and PIK3R2 exhibit opposing roles in cancer, necessitating distinct therapeutic considerations.
• PIK3R2 represents a promising therapeutic target due to its oncogenic activity and frequent upregulation in cancer.
• Further research into PIK3R2 regulatory mechanisms could unveil new avenues for cancer treatment.